Amplification of cortical serotonin release: an additional neurochemical action of the vigilance-promoting drug modafinil

Thomas Thorne

Last update: February 2, 2023

Modafinil - Serotonin

ABSTRACT

The present in vitro and in vivo studies examined the effects of modafinil on serotonergic transmission in the rat frontal cortex. In the in vitro study, modafinil (0.3-30 muM) increased electrically evoked, but not spontaneous, serotonin ([(3)H]5-HT) flux from cortical slices in a concentration-dependent manner. , while the indirect serotonin agonist dl-fenfluramine (1-15 muM) improved both spontaneous and evoked [(3)H]5-HT efflux.

The effects of modafinil were more pronounced when paroxetine blocked 5-HT reuptake. Unlike paroxetine (0.3-3 muM) and dl-fenfluramine (1-5 muM), modafinil failed to influence the absorption of [(3)H]5-HT. In the in vivo study, modafinil (3-100 mg/kg i.p.) increased dialysate levels of 5-HT, and the maximum effect was already achieved at the 30 mg/kg dose. dl-fenfluramine (5 mg/kg) induced an increase in 5-HT levels that was significantly greater than that shown by modafinil at 30 mg/kg.

In the presence of paroxetine (3 µM), the effect of modafinil at 30 mg/kg was greater than that observed in the absence of 5-HT reuptake inhibition. Finally, in the presence of the selective 5-HT(1A) receptor agonist, 8-OH-DPAT, modafinil at 100 mg/kg failed to affect dialysate 5-HT levels.These results demonstrate that modafinil regulates cortical serotonergic transmission and suggest that the drug acts preferentially by amplifying electro-neurosecretory coupling mechanisms and through mechanisms that do not involve the reuptake process.

References

table of Contents
    Add a header to start generating the table of contents